Aria Pharmaceuticals

Aria Pharmaceuticals developed an AI drug discovery platform that integrates and analyzes unrelated heterogenous data in one process.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

AI drug discovery, preclinical pharmaceutical research, Symphony platform

About Us

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that focuses on discovering and developing novel small molecule therapies for complex diseases. The company uses its proprietary platform combines artificial intelligence (AI) and biomedical data, to accelerate drug discovery and increase success rates in pharmaceutical research and development.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies